ArticleJournal of cancer research and clinical oncology2022

Dynamic contrast-enhanced MRI predicts PTEN protein expression which can function as a prognostic measure of progression-free survival in NPC patients.

Gang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.